Cardioprotection Through S -Nitros(yl)ation of Macrophage Migration Inhibitory Factor
Author(s) -
Peter Luedike,
Ulrike B. HendgenCotta,
Julia Sobierajski,
Matthias Totzeck,
Marcel Reeh,
Manfred Dewor,
Hongqi Lue,
Christoph Krisp,
Dirk Wolters,
Malte Kelm,
Jürgen Bernhagen,
Tienush Rassaf
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.069104
Subject(s) - macrophage migration inhibitory factor , cytoprotection , cardioprotection , medicine , in vivo , macrophage , pharmacology , cytokine , inflammation , microbiology and biotechnology , immunology , oxidative stress , biology , in vitro , biochemistry , ischemia
Macrophage migration inhibitory factor (MIF) is a structurally unique inflammatory cytokine that controls cellular signaling in human physiology and disease through extra- and intracellular processes. Macrophage migration inhibitory factor has been shown to mediate both disease-exacerbating and beneficial effects, but the underlying mechanism(s) controlling these diverse functions are poorly understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom